Henry F Blissenbach - Net Worth and Insider Trading

Henry F Blissenbach Net Worth

The estimated net worth of Henry F Blissenbach is at least $761,974 dollars as of 2024-09-20. Henry F Blissenbach is the President and CEO of Option Care Health Inc and owns about 24,136 shares of Option Care Health Inc (OPCH) stock worth over $761,974. Details can be seen in Henry F Blissenbach's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry F Blissenbach has not made any transactions after 2005-03-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Henry F Blissenbach

To

Henry F Blissenbach Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Henry F Blissenbach owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Option Care Health Inc (OPCH) .

Click here to see the complete history of Henry F Blissenbach’s form 4 insider trades.

Insider Ownership Summary of Henry F Blissenbach

Ticker Comapny Transaction Date Type of Owner
LGND Ligand Pharmaceuticals Inc 2006-07-27 director
OPCH Option Care Health Inc 2005-03-12 director & President and CEO

Henry F Blissenbach Latest Holdings Summary

Henry F Blissenbach currently owns a total of 1 stock. Henry F Blissenbach owns 24,136 shares of Option Care Health Inc (OPCH) as of March 12, 2005, with a value of $761,974.

Latest Holdings of Henry F Blissenbach

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPCH Option Care Health Inc 2005-03-12 24,136 31.57 761,974

Holding Weightings of Henry F Blissenbach


Henry F Blissenbach Form 4 Trading Tracker

According to the SEC Form 4 filings, Henry F Blissenbach has made a total of 0 transactions in Option Care Health Inc (OPCH) over the past 5 years. The most-recent trade in Option Care Health Inc is the sale of 0 shares on March 12, 2005, which brought Henry F Blissenbach around $0.

Insider Trading History of Henry F Blissenbach

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Henry F Blissenbach Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Henry F Blissenbach Ownership Network

Ownership Network List of Henry F Blissenbach

No Data

Ownership Network Relation of Henry F Blissenbach

Insider Network Chart

Henry F Blissenbach Owned Company Details

What does Ligand Pharmaceuticals Inc do?

Who are the key executives at Ligand Pharmaceuticals Inc?

Henry F Blissenbach is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .

Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary

Over the past 18 months, Henry F Blissenbach made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 54,701 shares made by Matthew E Korenberg , a net sale of 11,800 shares made by Andrew Reardon , and a net sale of 13,433 shares made by Octavio Espinoza .

In summary, during the past 3 months, insiders sold 38,603 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 2,500 shares, with a net sale of 36,103 shares. During the past 18 months, 100,021 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 93,521 shares.

Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ligand Pharmaceuticals Inc Insider Transactions

No Available Data

Henry F Blissenbach Mailing Address

Above is the net worth, insider trading, and ownership report for Henry F Blissenbach. You might contact Henry F Blissenbach via mailing address: 607 Pond View Dr, Mendota Heights Mn 55120.

Discussions on Henry F Blissenbach

No discussions yet.